Tuesday, October 22, 2019 9:07:42 AM
While I expect steep growth and getting to a $10million run rate 3rd quarter 2020, I am concerned about physicians that have tried but are not continuing to prescribe. Very hard to get a physician to try, but they seem to retain only about 85% as continuing to prescribe. Hope to see some better numbers, or at least an explanation in the quarterly report. Maybe it all relates to the reimbursement issue that they are working on.
Recent ECOR News
- electroCore Engages FNK IR to Execute Expanded Investor Relations Program • GlobeNewswire Inc. • 09/24/2024 12:00:00 PM
- Study Suggests Non-invasive Vagus Nerve Stimulation (nVNS) is effective in accelerating United States Air Force Pilot Training • GlobeNewswire Inc. • 09/10/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 09:05:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/06/2024 01:32:50 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/06/2024 01:32:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 12:46:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/19/2024 01:37:31 PM
- electroCore to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 08/08/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 08:15:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 08:11:24 PM
- electroCore Announces Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/07/2024 08:01:00 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 08/02/2024 08:05:40 PM
- electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 08/02/2024 08:05:00 PM
- Non-invasive Vagus Nerve Stimulation (nVNS) is effective at accelerating foreign language learning • GlobeNewswire Inc. • 08/01/2024 12:00:00 PM
- electroCore to Announce Second Quarter June 30, 2024 Financial Results on Wednesday, August 7, 2024 • GlobeNewswire Inc. • 07/31/2024 12:00:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 07/23/2024 04:09:24 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/18/2024 07:40:06 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 07/17/2024 09:15:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2024 09:06:03 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 07/10/2024 08:07:23 PM
- electroCore Announces the Commercial Launch of TAC-STIM™ • GlobeNewswire Inc. • 06/25/2024 12:00:00 PM
- electroCore to Join Russell Microcap® Index • GlobeNewswire Inc. • 06/11/2024 12:00:00 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 06/07/2024 08:33:08 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM